You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

IMIPENEM AND CILASTATIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Imipenem And Cilastatin, and when can generic versions of Imipenem And Cilastatin launch?

Imipenem And Cilastatin is a drug marketed by Acs Dobfar, Hospira Inc, and Hq Spclt Pharma. and is included in four NDAs.

The generic ingredient in IMIPENEM AND CILASTATIN is cilastatin sodium; imipenem. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cilastatin sodium; imipenem profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for IMIPENEM AND CILASTATIN?
  • What are the global sales for IMIPENEM AND CILASTATIN?
  • What is Average Wholesale Price for IMIPENEM AND CILASTATIN?
Drug patent expirations by year for IMIPENEM AND CILASTATIN
Recent Clinical Trials for IMIPENEM AND CILASTATIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlinePhase 3
Spero TherapeuticsPhase 3
Meiji Seika Pharma Co., Ltd.Phase 3

See all IMIPENEM AND CILASTATIN clinical trials

Pharmacology for IMIPENEM AND CILASTATIN

US Patents and Regulatory Information for IMIPENEM AND CILASTATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090577-001 Dec 21, 2011 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira Inc IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090825-002 Nov 16, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Acs Dobfar IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090577-002 Dec 21, 2011 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira Inc IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090825-001 Nov 16, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.